界面活性剤による甲状腺ペルオキシダーゼの部分精製とその過酸化水素によるスペクトル変化
スポンサーリンク
概要
- 論文の詳細を見る
Thyroid peroxidase (TPO) was partially purified from hog thyroid microsomes after solubilization by means of deoxycholate treatment followed by ammonium sulfate fractionation and affinity chromatography with Con A Sepharose. The absorption spectra of the preparation showed the maxima at around 410 nm for oxidized form, 422 nm for dithionitereduced form and 422 nm for CO complex of reduced form. The cyanide difference spectrum showed a peak at 431 nm and a trough at 403 nm. This preparation was contaminated with little cytochrome b5 and it was shown that the TPO preparation was able to be used for the following spectrophotometric experiments.<BR>The addition of H<SUB>2</SUB>O<SUB>2</SUB> to the TPO preparation induced the characteristic change in the difference spectrum with a peak at 430 nm and a trough at 407 nm, which was gradually disappeared in a few minutes, but at the high concentration of H<SUB>2</SUB>O<SUB>2</SUB> (35 μM) the trough at 411 nm was observed after decomposition of H<SUB>2</SUB>O<SUB>2</SUB> accompanying loss of peroxidase activity. This deepening of the trough caused the heme degradation which was dependent with the concentration of H202 added and to less extent at the low concentration of H202 (3.5 μM). Since the difference spectrum produced by the addition of small amount of H<SUB>2</SUB>O<SUB>2</SUB> disappeared rapidly after the addition of KI or ascorbate and resembled the spectral change due to the formation of Compound II in the reaction of other perioxidases, it was concluded that the difference spectrum with a peak at 430 nm and a trough at 407 nm observed after the addition of H<SUB>2</SUB>O<SUB>2</SUB> was ascribable to the formation of Compound II of TPO. Although Compound I was not observed under the experimental conditions used, the results were accounted for the presence of I bound to TPO or other endogeneous reducing agents. We tentatively concluded that Compound I and Compound II are formed in the reaction of TPO with H<SUB>2</SUB>O<SUB>2</SUB> as well as in that of horseradish peroxidase.
- 日本内分泌学会の論文
著者
関連論文
- 55 ヒト胎盤NAD依存症15-hydroxy-prostaglandin dehydrogenase (PGHD) の精製とサブユニット構造
- 86. Dipeptidyl Aminopeptidase IV (DAP IV)活性染色の甲状腺細胞診への応用(甲状腺II)(一般講演・口演)(第33回日本臨床細胞学会総会)
- 間質に破骨細胞様巨細胞を伴った乳癌の1例
- 129. 甲状腺疾患におけるDipeptidyl Aminopeptidase IV (DAPIV)活性染色の有用性 : 第二報(甲状腺II)
- 87. 甲状腺疾患におけるDipeptidyl Aminopeptidase (DAP IV)活性染色の有用性(甲状腺II)(一般講演・口演)(第33回日本臨床細胞学会総会)
- 150.腹水細胞診において髄外造血を推定し得た非ホジキンリンパ腫 : B細胞型の一剖検例(第19群 リンパ腫・その他, 示説, 第22回日本臨床細胞学会秋期大会)
- TPOとその発現調節に関する最近の知見 - 甲状腺ペルオキシダーゼ遺伝子変異 -
- ワ1-甲3.小型類円形細胞を主体とする甲状腺腫瘍の細胞診 : 判定困難例へのDPPIV染色の応用 : ワークショップ1 : 小型円形細胞を主体とする腫瘍の細胞診 : 各分野ごとの小型円形細胞の鑑別診断上の問題点 : 3)甲状腺
- 110.細胞診における事務的作業のコンピューター化について(基礎2, 示説, 第27回日本臨床細胞学会秋期大会学術集会)
- 2.酵素染色 : 悪性リンパ腫を中心に(2)(教育シンポジウム, 教育研究部会, 第25回日本臨床細胞学会総会記事)
- Mycoplasma hominis によって惹起されたと考えられる早産の2例
- 界面活性剤による甲状腺ペルオキシダーゼの部分精製とその過酸化水素によるスペクトル変化
- ヒト血清Thyroglobulinおよひ抗Thyroglobulin自己抗体の酵素免疫測定法の研究
- 甲状腺穎粒系ヘム蛋白の分光学的研究